Concepedia

Maja J.A. deJonge

MJ

Statistics

Publications

3

Citations

78

H-Index

3

Active since

2005

Affiliations

Erasmus MC(Current)

Maja J.A. deJonge is an author at Erasmus MC specializing in tumor biology, drug safety, and molecular pharmacology.

Top concepts

Publications per year

2005–2019

3

Publications

3

Phase I and Pharmacokinetic Study of Oral Irinotecan Given Once Daily for 5 Days Every 3 Weeks in Combination With Capecitabine in Patients With Solid Tumors

Otto Soepenberg, Herlinde Dumez, Jaap Verweij et al. · Journal of Clinical Oncology · 2005 · 28 citations · Full text

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

Robin L. Jones, Mark J. Ratain, Peter J. O’Dwyer et al. · European Journal of Cancer · 2019 · 28 citations · Full text

A phase I, open-label study of the safety and pharmacokinetics (PK) of pazopanib (P) and lapatinib (L) administered concurrently

Maja J.A. deJonge, S. Savage, Jaap Verweij et al. · Journal of Clinical Oncology · 2006 · 22 citations

, , +18

1–3 of 3